These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21717439)

  • 21. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
    Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
    Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis the clinic and cytogenetics of myelodysplastic syndrome].
    Cen L; Zhou M; Zhao YH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):668-9. PubMed ID: 17160950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
    Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
    Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
    Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
    Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
    Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup.
    Giagounidis AA; Germing U; Strupp C; Hildebrandt B; Heinsch M; Aul C
    Ann Hematol; 2005 Sep; 84(9):569-71. PubMed ID: 15891887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
    Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impaired superoxide production by neutrophils in myelodysplastic syndrome: correlation with bone marrow karyotype].
    Uike N; Hashimoto M; Takeichi N; Kozuru M
    Rinsho Ketsueki; 1989 Jun; 30(6):830-4. PubMed ID: 2552193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
    Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
    Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
    van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
    Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
    Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
    Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31.
    Giagounidis AA; Germing U; Haase S; Hildebrandt B; Schlegelberger B; Schoch C; Wilkens L; Heinsch M; Willems H; Aivado M; Aul C
    Leukemia; 2004 Jan; 18(1):113-9. PubMed ID: 14586479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7.
    Crisà E; Kulasekararaj AG; Adema V; Such E; Schanz J; Haase D; Shirneshan K; Best S; Mian SA; Kizilors A; Cervera J; Lea N; Ferrero D; Germing U; Hildebrandt B; Martínez ABV; Santini V; Sanz GF; Solé F; Mufti GJ
    Leukemia; 2020 Sep; 34(9):2441-2450. PubMed ID: 32066866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytogenetic and clinical analysis of -7/7q- abnormalities in acute leukemia and myelodysplastic syndrome].
    Meng HT; Mai WY; Chen ZM; Lou JY; Jin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):460-3. PubMed ID: 15363131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient monosomy 7: a case series in children and review of the literature.
    Mantadakis E; Shannon KM; Singer DA; Finklestein J; Chan KW; Hilden JM; Sandler ES
    Cancer; 1999 Jun; 85(12):2655-61. PubMed ID: 10375115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB; Mallo M; Arenillas L; Salido M; Espinet B; Pedro C; Florensa L; Serrano S; Solé F
    Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis.
    Sugimori N; Kondo Y; Shibayama M; Omote M; Takami A; Sugimori C; Ishiyama K; Yamazaki H; Nakao S
    Eur J Haematol; 2009 Jan; 82(1):54-60. PubMed ID: 18801060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.
    Heerema NA; Nachman JB; Sather HN; La MK; Hutchinson R; Lange BJ; Bostrom B; Steinherz PG; Gaynon PS; Uckun FM;
    Leukemia; 2004 May; 18(5):939-47. PubMed ID: 14999294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.